Invention Grant
- Patent Title: Anti-nucleolin antibodies
-
Application No.: US16080720Application Date: 2017-03-07
-
Publication No.: US11357849B2Publication Date: 2022-06-14
- Inventor: Daniel Fernandes , Laura Schwartz , Natalie Sutkowski , Brian Hoel , Semyon Rubinchik
- Applicant: CharlestonPharma, LLC , MUSC Foundation for Research Development
- Applicant Address: US SC Charleston; US SC Charleston
- Assignee: CharlestonPharma, LLC,MUSC Foundation for Research Development
- Current Assignee: CharlestonPharma, LLC,MUSC Foundation for Research Development
- Current Assignee Address: US SC Charleston; US SC Charleston
- Agency: Parker Highlander PLLC
- International Application: PCT/US2017/021203 WO 20170307
- International Announcement: WO2017/156032 WO 20170914
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/18 ; A61P35/00 ; C07K16/30 ; C07K16/28 ; A61K39/00 ; A61K38/00
Abstract:
The present disclosure provides anti-nucleolin antibodies, methods of producing anti-nucleolin antibodies, and cells producing anti-nucleolin antibodies. Also provided are methods of using anti-nucleolin antibodies in treating malignant and non-malignant diseases.
Public/Granted literature
- US20190194334A1 ANTI-NUCLEOLIN ANTIBODIES Public/Granted day:2019-06-27
Information query
